Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech World Israel.
Press releases published on July 28, 2025
EIN Presswire Debuts Podcast with PR Insider Sherrie Handrinos on the Power of Influencer Marketing
EIN Presswire
·
July 28, 2025
“Heard on the Streets” podcast explores how brands are cashing in on social media strategy WASHINGTON , DC, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- EIN Presswire has launched its first audio podcast on Substack, and it’s diving into one of …
Morphisec Welcomes Cybersecurity Channel Veteran Frank Rauch as Advisory Board Member
EIN Presswire
·
July 28, 2025
Appointment Strengthens Morphisec’s Partner Strategy and Commitment to Prevention-First Anti-Ransomware Innovation BOSTON, MA, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- Morphisec, the world’s leading provider of prevention-first cybersecurity …
Healthy4U Integrates with Apple Health and Major Fitness Trackers, Unlocking a New Era of Deeply Personalized Wellness
EIN Presswire
·
July 28, 2025
Healthy4U now syncs with Apple Health and top trackers, delivering deeper insights and truly personalized health recommendations. TEL AVIV, TEL AVIV, ISRAEL, July 28, 2025 /EINPresswire.com/ -- Healthy4U, an Israeli health-tech startup and the first in …
Can-Fite Announces Up To $15.0 Million Public Offering
GlobeNewswire
·
July 28, 2025
$5.0 million upfront with up to an additional $10.0 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants RAMAT GAN, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: …
Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis
GlobeNewswire
·
July 28, 2025
JERUSALEM, July 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and protein replacement therapies, announced today that in a written response to a Type A meeting request, the U.S. Food and Drug …
Breakthrough Study from UCLA Demonstrate Can-Fite’s Piclidenoson as a Treatment for Vascular Dementia
GlobeNewswire
·
July 28, 2025
Ramat Gan, Israel, July 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory …